Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 1995 Apr 11;92(8):3566-70.
doi: 10.1073/pnas.92.8.3566.

Expression of the fms-like tyrosine kinase 4 gene becomes restricted to lymphatic endothelium during development

Affiliations

Expression of the fms-like tyrosine kinase 4 gene becomes restricted to lymphatic endothelium during development

A Kaipainen et al. Proc Natl Acad Sci U S A. .

Abstract

We have recently cloned the human fms-like tyrosine kinase 4 gene FLT4, whose protein product is related to two vascular endothelial growth factor receptors FLT1 and KDR/FLK1. Here the expression of FLT4 has been analyzed by in situ hybridization during mouse embryogenesis and in adult human tissues. The FLT4 mRNA signals first became detectable in the angioblasts of head mesenchyme, the cardinal vein, and extraembryonally in the allantois of 8.5-day postcoitus (p.c.) embryos. In 12.5-day p.c. embryos, the FLT4 signal decorated developing venous and presumptive lymphatic endothelia, but arterial endothelia were negative. During later stages of development, FLT4 mRNA became restricted to vascular plexuses devoid of red cells, representing developing lymphatic vessels. Only the lymphatic endothelia and some high endothelial venules expressed FLT4 mRNA in adult human tissues. Increased expression occurred in lymphatic sinuses in metastatic lymph nodes and in lymphangioma. Our results suggest that FLT4 is a marker for lymphatic vessels and some high endothelial venules in human adult tissues. They also support the theory on the venous origin of lymphatic vessels.

PubMed Disclaimer

References

    1. Semin Cancer Biol. 1992 Apr;3(2):65-71 - PubMed
    1. J Biol Chem. 1992 Jun 5;267(16):10931-4 - PubMed
    1. Biochem Biophys Res Commun. 1992 Sep 30;187(3):1579-86 - PubMed
    1. Blood. 1992 Nov 15;80(10):2548-55 - PubMed
    1. Radiographics. 1992 Nov;12(6):1175-89 - PubMed

Publication types

MeSH terms

Substances

LinkOut - more resources